Zoladex, a vital medication for battling breast cancer and endometriosis, is being withdrawn from the Australian market. This decision threatens to disrupt treatment for countless women, raising urgent concerns about access to life-changing care
Browsing: Hormone Therapy
Exciting news from Lipocine Inc.! The company has just unveiled a groundbreaking license and supply agreement for its innovative testosterone replacement therapy, TLANDO®, in Brazil. This strategic partnership is set to broaden access to this vital treatment across the Brazilian market, significantly boosting Lipocine's presence on the global stage.